Channel Therapeutics Corp...

NYSE: PTHS · Real-Time Price · USD
23.18
0.68 (3.02%)
At close: Aug 25, 2025, 3:59 PM
21.91
-5.48%
Pre-market: Aug 26, 2025, 05:04 AM EDT

Channel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-7.96M -7.38M -2.46M
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
1.8M 1.73M 110.15K
Other Working Capital
-1.1M 424.07K 227.26K
Other Non-Cash Items
328.93K 2.62M 140.43K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
34.63K 2.05M 640.86K
Operating Cash Flow
-5.79M -981.03K -1.57M
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a n/a n/a
Debt Repayment
321.43K 766.94K 400K
Common Stock Repurchased
-166.51K n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.22M
Financial Cash Flow
6.21M 1.02M 1.62M
Net Cash Flow
417.05K 41.32K 55.07K
Free Cash Flow
-5.79M -981.03K -1.57M